Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Millions	Jun. 30, 2023	Dec. 31, 2022
Current Assets:
Cash and cash equivalents	$ 319.8	$ 375.7
Accounts receivable, less allowance for credit losses	1,367.3	1,381.5
Inventories	2,275.8	2,147.2
Prepaid expenses and other current assets	425.1	522.9
Total Current Assets	4,387.9	4,427.3
Property, plant and equipment, net	1,975.0	1,872.5
Goodwill	8,743.7	8,580.2
Intangible assets, net	5,027.7	5,063.8
Other assets	1,160.0	1,122.2
Total Assets	21,294.3	21,066.0
Current Liabilities:
Accounts payable	354.6	354.1
Income taxes payable	81.6	38.5
Other current liabilities	1,277.6	1,421.3
Current portion of long-term debt	520.0	544.3
Total Current Liabilities	2,233.7	2,358.2
Deferred income taxes, net	474.9	474.8
Long-term income tax payable	375.7	421.2
Other long-term liabilities	642.0	632.6
Long-term debt	5,189.4	5,152.2
Total Liabilities	8,915.8	9,039.0
Commitments and Contingencies (Note 16)
Stockholders' Equity:
Common stock, $0.01 par value, one billion shares authorized, 315.8 million shares as of June 30, 2023 (313.8 million as of December 31, 2022) issued	3.2	3.1
Paid-in capital	9,766.0	9,504.4
Retained earnings	9,902.3	9,559.3
Accumulated other comprehensive loss	(177.8)	(179.3)
Treasury stock, 107.0 million shares as of June 30, 2023 (104.8 million as of December 31, 2022)	(7,122.2)	(6,867.2)
Total Zimmer Biomet Holdings, Inc. stockholders' equity	12,371.5	12,020.3
Noncontrolling interest	7.1	6.7
Total Stockholders' Equity	12,378.6	12,027.0
Total Liabilities and Stockholders' Equity	$ 21,294.3	$ 21,066.0